Brendan Saloner Selected Research

Buprenorphine (Subutex)

12/2022	Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine.
11/2022	Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.
7/2022	Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.
1/2022	Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020.
1/2022	Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic.
1/2022	Differences in buprenorphine treatment quality across physician provider specialties.
1/2022	Medicaid Managed Care: Access To Primary Care Providers Who Prescribe Buprenorphine.
1/2022	A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid.
12/2021	Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
1/2021	It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan Saloner Research Topics

Disease

27	Opioid-Related Disorders (Opiate Addiction) 12/2022 - 01/2016
10	Substance-Related Disorders (Drug Abuse) 12/2022 - 08/2014
10	COVID-19 11/2022 - 01/2020
9	Opiate Overdose 04/2022 - 10/2014
3	Pain (Aches) 01/2022 - 04/2015
2	Chronic Disease (Chronic Diseases) 01/2021 - 01/2019
2	Drug Overdose 01/2020 - 11/2018
2	Mental Disorders (Mental Disorder) 01/2019 - 06/2017
2	Alcoholism (Alcohol Abuse) 01/2018 - 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Low Back Pain (Lumbago) 07/2017
1	Sinusitis 07/2017
1	Chronic Pain 10/2014

Drug/Important Bio-Agent (IBA)

25	Buprenorphine (Subutex)FDA LinkGeneric 12/2022 - 06/2017
18	Opioid Analgesics (Opioids)IBA 11/2022 - 10/2014
10	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
8	Methadone (Dolophine)FDA LinkGeneric 11/2022 - 01/2016
3	Naloxone Drug Combination Buprenorphine FDA Link 01/2019 - 01/2017
2	RV 538 (PDMP)IBA 04/2022 - 01/2021
2	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 01/2020
2	Prescription DrugsIBA 11/2020 - 01/2019
2	Medical MarijuanaIBA 04/2015 - 10/2014
1	SmokeIBA 12/2022
1	BenzodiazepinesIBA 01/2022
1	vivitrol FDA Link 12/2020
1	VaccinesIBA 01/2020
1	Heroin (Diamorphine)IBA 01/2020
1	N-nitrosoiminodiacetic acidIBA 11/2018
1	ORALIT (ORS)IBA 10/2018
1	Naloxone (Narcan)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017

Therapy/Procedure

2	Ambulatory Care (Outpatient Care) 01/2021 - 01/2019
2	Therapeutics 12/2017 - 01/2016
1	Continuity of Patient Care 01/2022
1	Prenatal Care (Care, Prenatal) 01/2021
1	Aftercare (After-Treatment) 01/2020